US Patent Issued to Arizona Board of Regents on Behalf of the University of Arizona on Aug. 25 for "Small molecule inhibitors of SARS-CoV-2 viral replication and uses thereof" (Arizona Inventors)

ALEXANDRIA, Va., Aug. 25 -- United States Patent no. 12,715,896, issued on Aug. 25, was assigned to Arizona Board of Regents on Behalf of the University of Arizona (Tucson, Ariz.).

"Small molecule inhibitors of SARS-CoV-2 viral replication and uses thereof" was invented by Jun Wang (Tucson, Ariz.) and Chunlong Ma (Tucson, Ariz.).

According to the abstract* released by the U.S. Patent & Trademark Office: "This invention is in the field of medicinal pharmacology. In particular, the present invention relates to pharmaceutical agents which function as inhibitors of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral replication and/or SARS-CoV-2 related viral 3CL protease (Mpro) activity. The invention further relates to method...